Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma
Sharareh Siamakpour‐Reihani(Duke University), Angeles Alvarez Secord(Duke University), T.B. Turner(Duke Medical Center), Kouros Owzar(Duke University), Chen Jiang(University of Hong Kong), Jeffrey R. Marks(Duke Medical Center), Andrew Berchuck(General Marble (Greece)), Mark W. Dewhirst(Duke Medical Center), Yiwen Deng(Duke University), Sarah M. Bean(Duke Medical Center), Janet K. Horton(University of North Carolina at Chapel Hill)
Cited by 68
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
|JNCI Journal of the National Cancer Institute|2006|923
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917